Phillip P. Chan
CIK: 0001442786
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cytosorbents Corp
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 15, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct3.8K shares at avg. $6.00$23K - Sep 4, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct200K shares at avg. $0.35$70K - Jun 15, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct10.3K shares at avg. $0.43$4K - Jun 12, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct251.1K shares at avg. $0.40$100K - Nov 18, 2025CTSO
Cytosorbents Corp
Award(A)Direct100K shares at avg. $0.64$64K - Aug 8, 2025CTSO
Cytosorbents Corp
Award(A)Direct105.6K shares- - Feb 24, 2025CTSO
Cytosorbents Corp
Out-of-Term(O)Direct34.2K shares at avg. $1.13$39K - Jan 17, 2025CTSO
Cytosorbents Corp
In-the-Money(X)Direct90.8K shares at avg. $1.00$91K - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries A Right Warrants
90.8K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries B Right Warrants
90.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 3,774 | $6.00 | $22,644 | Direct |
| Sep 4, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 200,000 | $0.35 | $70,000 | Direct |
| Jun 15, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 10,333 | $0.43 | $4,443 | Direct |
| Jun 12, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 251,136 | $0.40 | $100,454 | Direct |
| Nov 18, 2025 | CTSO Cytosorbents Corp | Award(A) | 100,000 | $0.64 | $64,000 | Direct |
| Aug 8, 2025 | CTSO Cytosorbents Corp | Award(A) | 105,600 | - | - | Direct |
| Feb 24, 2025 | CTSO Cytosorbents Corp | Out-of-Term(O) | 34,168 | $1.13 | $38,610 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | In-the-Money(X) | 90,832 | $1.00 | $90,832 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series A Right Warrants | 90,832 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series B Right Warrants | 90,832 | - | - | Direct |
1-10 of 10 transactions
About Chan Phillip P.
Chan Phillip P. (SEC CIK 0001442786) files insider reports with the SEC as Chief Executive Officer of Cytosorbents Corp (CTSO).
Signal8 holds 7 ownership filings by Chan Phillip P., all Form 4s, filed between Jan 22, 2025 and Sep 16, 2026. Those filings report 10 transactions, from Jan 17, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chan Phillip P.'s filings is in PRINCETON, NJ.
Recent filings by Chan Phillip P.
- Sep 15, 2026: Open-market purchase of CTSO shares (Form 4, code P).
- Sep 4, 2026: Open-market purchase of CTSO shares (Form 4, code P).
- Jun 15, 2026: Open-market purchase of CTSO shares (Form 4, code P).
- Jun 12, 2026: Open-market purchase of CTSO shares (Form 4, code P).
- Nov 18, 2025: Grant or award of CTSO shares (Form 4, code A).
Other insiders filing for Cytosorbents Corp (CTSO)
- Capponi Vincent, President and COO
- Sobel Alan D., Director
- MARIANI PETER J, Chief Financial Officer
- Jones Edward Raymond, Director
- BATOR MICHAEL G., Director
- Kim Jiny, Director